OpenURL Connection Search

Select item for more details and to access through your institution.

Schedule-dependent antitumor effects of 5-fluorouracil combined with sorafenib in hepatocellular carcinoma.
Published in:
2013
By:
- Lifen Deng;
- Zhenggang Ren;
- Qingan Jia;
- Weizhong Wu;
- Hujia Shen;
- Yanhong Wang;
- Deng, Lifen;
- Ren, Zhenggang;
- Jia, Qingan;
- Wu, Weizhong;
- Shen, Hujia;
- Wang, Yanhong
Publication type:
journal article
Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection.
Published in:
Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 5, p. 773, doi. 10.1007/s00432-012-1343-7
By:
- Chen, Xiaohong;
- Zhang, Boheng;
- Yin, Xin;
- Ren, Zhenggang;
- Qiu, Shuangjian;
- Zhou, Jian
Publication type:
Article
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trial.
Published in:
Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-00886-2
By:
- Wang, Feng;
- Qin, Shukui;
- Sun, Xinchen;
- Ren, Zhenggang;
- Meng, Zhiqiang;
- Chen, Zhendong;
- Chai, Xiaoli;
- Xiong, Jianping;
- Bai, Yuxian;
- Yang, Lin;
- Zhu, Hong;
- Fang, Weijia;
- Lin, Xiaoyan;
- Chen, Xiaoming;
- Li, Enxiao;
- Wang, Linna;
- Yan, Ping;
- Zou, Jianjun
Publication type:
Article
Higher matrix stiffness as an independent initiator triggers epithelial-mesenchymal transition and facilitates HCC metastasis.
Published in:
Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13045-019-0795-5
By:
- Dong, Yinying;
- Zheng, Qiongdan;
- Wang, Zhiming;
- Lin, Xiahui;
- You, Yang;
- Wu, Sifan;
- Wang, Yaohui;
- Hu, Chao;
- Xie, Xiaoying;
- Chen, Jie;
- Gao, Dongmei;
- Zhao, Yan;
- Wu, Weizhong;
- Liu, Yinkun;
- Ren, Zhenggang;
- Chen, Rongxin;
- Cui, Jiefeng
Publication type:
Article
Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.
Published in:
Cellular Physiology & Biochemistry (Karger AG), 2015, v. 36, n. 3, p. 1223, doi. 10.1159/000430292
By:
- Tang, Wenqing;
- Feng, Xuemei;
- Zhang, Si;
- Ren, Zhenggang;
- Liu, Yinkun;
- Yang, Biwei;
- lv, Bei;
- Cai, Yu;
- Xia, Jinglin;
- Ge, Ningling
Publication type:
Article
Development and Preliminary Validation of a Novel Convolutional Neural Network Model for Predicting Treatment Response in Patients with Unresectable Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy.
Published in:
Journal of Digital Imaging, 2024, v. 37, n. 4, p. 1282, doi. 10.1007/s10278-024-01003-2
By:
- Quan, Bing;
- Li, Jinghuan;
- Mi, Hailin;
- Li, Miao;
- Liu, Wenfeng;
- Yao, Fan;
- Chen, Rongxin;
- Shan, Yan;
- Xu, Pengju;
- Ren, Zhenggang;
- Yin, Xin
Publication type:
Article
Real-world study of hepatic artery infusion chemotherapy combined with anti-PD-1 immunotherapy for hepatocellular carcinoma patients with portal vein tumor thrombus.
Published in:
Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241231252
By:
- Li, Jinghuan;
- Quan, Bing;
- Liu, Wenfeng;
- Zhao, Menglong;
- Yao, Fan;
- Chen, Rongxin;
- Ren, Zhenggang;
- Yin, Xin
Publication type:
Article
γ-Glutamyltranspeptidase is a Prognostic Marker of Survival and Recurrence in Radiofrequency-Ablation Treatment of Hepatocellular Carcinoma.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 9, p. 3084, doi. 10.1245/s10434-014-3724-4
By:
- Ma, Hui;
- Zhang, Lan;
- Tang, Bei;
- Wang, Yan;
- Chen, Rongxin;
- Zhang, Boheng;
- Chen, Yi;
- Ge, Ningling;
- Wang, Yanhong;
- Gan, Yuhong;
- Ye, Shenglong;
- Ren, Zhenggang
Publication type:
Article
Prognostic Significance of Alpha-fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 11, p. 3540, doi. 10.1245/s10434-012-2368-5
By:
- Wang, Yan;
- Chen, Yi;
- Ge, Ningling;
- Zhang, Lan;
- Xie, Xiaoying;
- Zhang, Jubo;
- Chen, Rongxin;
- Wang, Yanhong;
- Zhang, Boheng;
- Xia, Jinglin;
- Gan, Yuhong;
- Ren, Zhenggang;
- Ye, Shenglong
Publication type:
Article
The Significance of MMP-9 Over MMP-2 in HCC Invasiveness and Recurrence of Hepatocellular Carcinoma After Curative Resection.
Published in:
Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, p. 375, doi. 10.1245/s10434-011-1836-7
By:
- Chen, Rongxin;
- Cui, Jiefeng;
- Xu, Changde;
- Xue, Tongchun;
- Guo, Kun;
- Gao, Dongmei;
- Liu, Yinkun;
- Ye, Shenglong;
- Ren, Zhenggang
Publication type:
Article
Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation.
Published in:
Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0761-z
By:
- Wu, Sifan;
- Zheng, Qiongdan;
- Xing, Xiaoxia;
- Dong, Yinying;
- Wang, Yaohui;
- You, Yang;
- Chen, Rongxin;
- Hu, Chao;
- Chen, Jie;
- Gao, Dongmei;
- Zhao, Yan;
- Wang, Zhiming;
- Xue, Tongchun;
- Ren, Zhenggang;
- Cui, Jiefeng
Publication type:
Article
Case Series of Steroid-Resistant Immune Checkpoint Inhibitor Associated Myocarditis: A Comparative Analysis of Corticosteroid and Tofacitinib Treatment.
Published in:
Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.770631
By:
- Wang, Cong;
- Lin, Jinyi;
- Wang, Yan;
- Hsi, David H.;
- Chen, Jiahui;
- Liu, Tianshu;
- Zhou, Yuhong;
- Ren, Zhenggang;
- Zeng, Zhaochong;
- Cheng, Leilei;
- Ge, Junbo
Publication type:
Article
IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211036544
By:
- Hack, Stephen P.;
- Verret, Wendy;
- Mulla, Sohail;
- Liu, Bo;
- Wang, Yulei;
- Macarulla, Teresa;
- Ren, Zhenggang;
- El-Khoueiry, Anthony B.;
- Zhu, Andrew X.
Publication type:
Article
IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer.
Published in:
Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211036544
By:
- Hack, Stephen P.;
- Verret, Wendy;
- Mulla, Sohail;
- Liu, Bo;
- Wang, Yulei;
- Macarulla, Teresa;
- Ren, Zhenggang;
- El-Khoueiry, Anthony B.;
- Zhu, Andrew X.
Publication type:
Article
A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma.
Published in:
Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919889001
By:
- Qin, Shukui;
- Chan, Stephen Lam;
- Sukeepaisarnjaroen, Wattana;
- Han, Guohong;
- Choo, Su Pin;
- Sriuranpong, Virote;
- Pan, Hongming;
- Yau, Thomas;
- Guo, Yabing;
- Chen, Minshan;
- Ren, Zhenggang;
- Xu, Jianming;
- Yen, Chia-Jui;
- Lin, Zhong-Zhe;
- Manenti, Luigi;
- Gu, Yi;
- Sun, Yongjian;
- Tiedt, Ralph;
- Hao, Lu;
- Song, Wenjie
Publication type:
Article
Higher Matrix Stiffness Upregulates Osteopontin Expression in Hepatocellular Carcinoma Cells Mediated by Integrin β1/GSK3β/β-Catenin Signaling Pathway.
Published in:
PLoS ONE, 2015, v. 10, n. 8, p. 1, doi. 10.1371/journal.pone.0134243
By:
- You, Yang;
- Zheng, Qiongdan;
- Dong, Yinying;
- Wang, Yaohui;
- Zhang, Lan;
- Xue, Tongchun;
- Xie, Xiaoying;
- Hu, Chao;
- Wang, Zhiming;
- Chen, Rongxin;
- Wang, Yanhong;
- Cui, Jiefeng;
- Ren, Zhenggang
Publication type:
Article
Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma.
Published in:
PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123175
By:
- Dong, Hua;
- Zhang, Lan;
- Qian, Ziliang;
- Zhu, Xuehua;
- Zhu, Guanshan;
- Chen, Yunqin;
- Xie, Xiaoying;
- Ye, Qinghai;
- Zang, Jie;
- Ren, Zhenggang;
- Ji, Qunsheng
Publication type:
Article
SAFFRON-104: a phase Ib/II study of sitravatinib alone or with tislelizumab in advanced hepatocellular carcinoma and gastric cancer/gastroesophageal junction cancer.
Published in:
Cancer Immunology, Immunotherapy, 2024, v. 73, n. 11, p. 1, doi. 10.1007/s00262-024-03806-2
By:
- Li, Jin;
- Bai, Yuxian;
- Chen, Zhendong;
- Ying, Jieer;
- Guo, Yabing;
- Fang, Weijia;
- Zhang, Feng;
- Xiong, Jianping;
- Zhang, Tao;
- Meng, Zhiqiang;
- Zhang, Jingdong;
- Ren, Zhenggang;
- Hao, Chunyi;
- Chen, Yajin;
- Lin, Xiaoyan;
- Pan, Hongming;
- Zhou, Fuxiang;
- Li, Xin;
- Yu, Fan;
- Zhang, Juan
Publication type:
Article
Development and Validation of a Nomogram for Patients Undergoing Transarterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy.
Published in:
Journal of Hepatocellular Carcinoma, 2024, v. 11, p. 693, doi. 10.2147/JHC.S444682
By:
- Diyang Xie;
- Zhongchen Li;
- Jia Yuan;
- Xin Yin;
- Rongxin Chen;
- Lan Zhang;
- Zhenggang Ren
Publication type:
Article
Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation.
Published in:
Gastroenterology Research & Practice, 2021, p. 1, doi. 10.1155/2021/8878417
By:
- Ma, Hui;
- Li, Zhongchen;
- Yuan, Jia;
- Zhang, Lan;
- Xie, Xiaoying;
- Yin, Xin;
- Chen, Rongxin;
- Ren, Zhenggang
Publication type:
Article
Matrix stiffness‐mediated effects on macrophages polarization and their LOXL2 expression.
Published in:
FEBS Journal, 2021, v. 288, n. 11, p. 3465, doi. 10.1111/febs.15566
By:
- Xing, Xiaoxia;
- Wang, Yaohui;
- Zhang, Xi;
- Gao, Xiangyu;
- Li, Miao;
- Wu, Sifan;
- Zhao, Yan;
- Chen, Jie;
- Gao, Dongmei;
- Chen, Rongxin;
- Ren, Zhenggang;
- Zhang, Kezhi;
- Cui, Jiefeng
Publication type:
Article
A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394.
Published in:
Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 389, doi. 10.1159/000535338
By:
- Qin, Shukui;
- Fang, Weijia;
- Ren, Zhenggang;
- Ou, Shuangyan;
- Lim, Ho Yeong;
- Zhang, Feng;
- Lee, Kin Chung;
- Choi, Hye Jin;
- Tong, Jiandong;
- Tao, Min;
- Xu, Aibing;
- Cheng, Ashley;
- Lu, Chang-Hsien;
- Chiu, Chang-Fang;
- Wahid, Mohamed Ibrahim Abdul;
- Kamble, Shital;
- Norquist, Josephine M.;
- Zhong, Wenyan;
- Li, Chen;
- Chen, Zhendong
Publication type:
Article
Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection Exhibited Favorable Survival from Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Published in:
Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 344, doi. 10.1159/000534446
By:
- Du, Qi;
- Yuan, Jia;
- Ren, Zhenggang
Publication type:
Article
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition).
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 5, p. 405, doi. 10.1159/000530495
By:
- Zhou, Jian;
- Sun, Huichuan;
- Wang, Zheng;
- Cong, Wenming;
- Zeng, Mengsu;
- Zhou, Weiping;
- Bie, Ping;
- Liu, Lianxin;
- Wen, Tianfu;
- Kuang, Ming;
- Han, Guohong;
- Yan, ZhiPing;
- Wang, Maoqiang;
- Liu, Ruibao;
- Lu, Ligong;
- Ren, Zhenggang;
- Zeng, ZhaoChong;
- Liang, Ping;
- Liang, Changhong;
- Chen, Min
Publication type:
Article
Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular Carcinoma.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 2, p. 1, doi. 10.1159/000526638
By:
- Ren, Zhenggang;
- Shao, Guoliang;
- Shen, Jie;
- Zhang, Li;
- Zhu, Xu;
- Fang, Weijia;
- Sun, Guoping;
- Bai, Yuxian;
- Wu, Jianbing;
- Liu, Lianxin;
- Yuan, Yuan;
- Zhang, Jingdong;
- Li, Zhen;
- Zhang, Ling;
- Yin, Tao;
- Wu, Jincai;
- Hou, Xiaoli;
- Wang, Qingyu;
- Zhu, Jun;
- Fan, Jia
Publication type:
Article
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial.
Published in:
Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 72, doi. 10.1159/000527175
By:
- Ren, Zhenggang;
- Ducreux, Michel;
- Abou-Alfa, Ghassan K.;
- Merle, Philippe;
- Fang, Weijia;
- Edeline, Julien;
- Li, Zhiwei;
- Wu, Lihua;
- Assenat, Eric;
- Hu, Sheng;
- Rimassa, Lorenza;
- Zhang, Tao;
- Blanc, Jean-Frédéric;
- Pan, Hongming;
- Ross, Paul;
- Yen, Chia-Jui;
- Tran, Albert;
- Shao, Guoliang;
- Bouattour, Mohamed;
- Chen, Yajin
Publication type:
Article
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 500, doi. 10.1159/000516470
By:
- Ren, Zhenggang;
- Qin, Shukui;
- Meng, Zhiqiang;
- Chen, Zhendong;
- Chai, Xiaoli;
- Xiong, Jianping;
- Bai, Yuxian;
- Yang, Lin;
- Zhu, Hong;
- Fang, Weijia;
- Lin, Xiaoyan;
- Chen, Xiaoming;
- Li, Enxiao;
- Wang, Linna;
- Yan, Ping;
- Zou, Jianjun
Publication type:
Article
A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 500, doi. 10.1159/000516470
By:
- Ren, Zhenggang;
- Qin, Shukui;
- Meng, Zhiqiang;
- Chen, Zhendong;
- Chai, Xiaoli;
- Xiong, Jianping;
- Bai, Yuxian;
- Yang, Lin;
- Zhu, Hong;
- Fang, Weijia;
- Lin, Xiaoyan;
- Chen, Xiaoming;
- Li, Enxiao;
- Wang, Linna;
- Yan, Ping;
- Zou, Jianjun
Publication type:
Article
Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study.
Published in:
Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 296, doi. 10.1159/000513486
By:
- Qin, Shukui;
- Ren, Zhenggang;
- Feng, Yin-Hsun;
- Yau, Thomas;
- Wang, Baocheng;
- Zhao, Haitao;
- Bai, Yuxian;
- Gu, Shanzhi;
- Li, Lindong;
- Hernandez, Sairy;
- Xu, Derek-Zhen;
- Mulla, Sohail;
- Wang, Yifan;
- Shao, Hui;
- Cheng, Ann Lii
Publication type:
Article
First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.
Published in:
Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.771045
By:
- Liu, Wenfeng;
- Quan, Bing;
- Lu, Shenxin;
- Tang, Bei;
- Li, Miao;
- Chen, Rongxin;
- Ren, Zhenggang;
- Yin, Xin
Publication type:
Article
Camrelizumab plus oxaliplatin‐based chemotherapy as first‐line therapy for advanced biliary tract cancer: A multicenter, phase 2 trial.
Published in:
International Journal of Cancer, 2021, v. 149, n. 11, p. 1944, doi. 10.1002/ijc.33751
By:
- Chen, Xinni;
- Qin, Shukui;
- Gu, Shanzhi;
- Ren, Zhenggang;
- Chen, Zhendong;
- Xiong, Jianping;
- Liu, Ying;
- Meng, Zhiqiang;
- Zhang, Xiao;
- Wang, Linna;
- Zhang, Xiaojing;
- Zou, Jianjun
Publication type:
Article
Peripheral blood neutrophil count as a prognostic factor for patients with hepatocellular carcinoma treated with sorafenib.
Published in:
Molecular & Clinical Oncology, 2017, v. 7, n. 5, p. 837, doi. 10.3892/mco.2017.1416
By:
- JIA YUAN;
- HONGMING LIANG;
- JINGHUAN LI;
- MIAO LI;
- BEI TANG;
- HUI MA;
- XIAOYING XIE;
- XIN YIN;
- LAN ZHANG;
- ZHENGGANG REN
Publication type:
Article
Transarterial Chemoembolization (TACE) Combined with Sorafenib in Treatment of HBV Background Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score Matching Study.
Published in:
BioMed Research International, 2019, p. 1, doi. 10.1155/2019/2141859
By:
- Yuan, Jia;
- Yin, Xin;
- Tang, Bei;
- Ma, Hui;
- Zhang, Lan;
- Li, Lixin;
- Chen, Rongxin;
- Xie, Xiaoying;
- Ren, Zhenggang
Publication type:
Article
Expression and Clinical Significance of MPS-1 in Hepatocellular Carcinoma.
Published in:
International Journal of General Medicine, 2021, v. 14, p. 9145, doi. 10.2147/IJGM.S334378
By:
- Jiang, He;
- Yuan, Feifei;
- Zhao, Zhiying;
- Xue, Tongchun;
- Ge, Ningling;
- Ren, Zhenggang;
- Zhang, Lan
Publication type:
Article
IDO and intra-tumoral neutrophils were independent prognostic factors for overall survival for hepatocellular carcinoma.
Published in:
2019
By:
- Wang, Yan;
- Yao, Rongrong;
- Zhang, Lan;
- Xie, Xiaoying;
- Chen, Rongxin;
- Ren, Zhenggang
Publication type:
journal article
Randomized Phase 3 LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib Plus Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma Not Amenable to Curative Treatment.
Published in:
CardioVascular & Interventional Radiology, 2022, v. 45, n. 4, p. 405, doi. 10.1007/s00270-021-03031-9
By:
- Llovet, Josep M.;
- Vogel, Arndt;
- Madoff, David C.;
- Finn, Richard S.;
- Ogasawara, Sadahisa;
- Ren, Zhenggang;
- Mody, Kalgi;
- Li, Jerry J.;
- Siegel, Abby B.;
- Dubrovsky, Leonid;
- Kudo, Masatoshi
Publication type:
Article
ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway.
Published in:
International Journal of Oncology, 2020, v. 57, n. 3, p. 845, doi. 10.3892/ijo.2020.5092
By:
- Wu, Man;
- Zhou, Yuhong;
- Fei, Chengming;
- Chen, Tianyi;
- Yin, Xin;
- Zhang, Lan;
- Ren, Zhenggang
Publication type:
Article
Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study.
Published in:
Drug Design, Development & Therapy, 2021, v. 15, p. 1873, doi. 10.2147/DDDT.S304857
By:
- Li, Hui;
- Qin, Shukui;
- Liu, Ying;
- Chen, Zhendong;
- Ren, Zhenggang;
- Xiong, Jianping;
- Meng, Zhiqiang;
- Zhang, Xiao;
- Wang, Linna;
- Zhang, Xiaojing;
- Zou, Jianjun
Publication type:
Article
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression.
Published in:
2021
By:
- Ryoo, Baek-Yeol;
- Cheng, Ann-Li;
- Ren, Zhenggang;
- Kim, Tae-You;
- Pan, Hongming;
- Rau, Kun-Ming;
- Choi, Hye Jin;
- Park, Joong-Won;
- Kim, Jee Hyun;
- Yen, Chia Jui;
- Lim, Ho Yeong;
- Zhou, Dongli;
- Straub, Josef;
- Scheele, Juergen;
- Berghoff, Karin;
- Qin, Shukui
Publication type:
journal article
JS-K, a novel non-ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c-Jun phosphorylation via multiple MAP kinase pathways.
Published in:
Journal of Cellular Physiology, 2003, v. 197, n. 3, p. 426, doi. 10.1002/jcp.10380
By:
- Zhenggang Ren;
- Siddhartha Kar;
- Ziqiu Wang;
- Meifang Wang;
- Joseph E. Saavedra;
- Brian I. Carr
Publication type:
Article
Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia.
Published in:
Communications Biology, 2018, v. 1, n. 1, p. N.PAG, doi. 10.1038/s42003-018-0177-5
By:
- Ma, Hui;
- Xie, Liqi;
- Zhang, Lan;
- Yin, Xin;
- Jiang, Hucong;
- Xie, Xiaoying;
- Chen, Rongxin;
- Lu, Haojie;
- Ren, Zhenggang
Publication type:
Article
The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis.
Published in:
International Journal of Biological Markers, 2021, v. 36, n. 3, p. 40, doi. 10.1177/17246008211032689
By:
- Liu, Wenfeng;
- Hu, Keshu;
- Zhang, Feng;
- Lu, Shenxin;
- Chen, Rongxin;
- Ren, Zhenggang;
- Yin, Xin
Publication type:
Article
Analysis by Treatment Period and Liver Function in EMERALD-1: Phase 3 Study of Durvalumab (D) With/Without Bevacizumab (B) With Transarterial Chemoembolization (TACE) in Unresectable Hepatocellular Carcinoma (uHCC) Eligible for Embolization.
Published in:
Journal of Oncology Navigation & Survivorship, 2024, v. 15, n. 10, p. 327
By:
- Chan, Stephen L.;
- Kudo, Masatoshi;
- Decaens, Thomas;
- Erinjeri, Joseph P.;
- Qin, Shukui;
- Ren, Zhenggang;
- Arai, Yasuaki;
- Bouattour, Mohamed;
- Breder, Valeriy V.
Publication type:
Article
Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.
Published in:
2021
By:
- Okusaka, Takuji;
- Ikeda, Kenji;
- Kudo, Masatoshi;
- Finn, Richard;
- Qin, Shukui;
- Han, Kwang-Hyub;
- Cheng, Ann-Lii;
- Piscaglia, Fabio;
- Kobayashi, Masahiro;
- Sung, Max;
- Chen, Minshan;
- Wyrwicz, Lucjan;
- Yoon, Jung-Hwan;
- Ren, Zhenggang;
- Mody, Kalgi;
- Dutcus, Corina;
- Tamai, Toshiyuki;
- Ren, Min;
- Hayato, Seiichi;
- Kumada, Hiromitsu
Publication type:
journal article
NLRP3/IL‐1β induced myeloid‐derived suppressor cells recruitment and PD‐L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma.
Published in:
MedComm, 2023, v. 4, n. 6, p. 1, doi. 10.1002/mco2.447
By:
- Liu, Wenfeng;
- Zhang, Feng;
- Quan, Bing;
- Yao, Fan;
- Chen, Rongxin;
- Ren, Zhenggang;
- Yin, Xin
Publication type:
Article
Activation of Piezo1 contributes to matrix stiffness‐induced angiogenesis in hepatocellular carcinoma.
Published in:
Cancer Communications, 2022, v. 42, n. 11, p. 1162, doi. 10.1002/cac2.12364
By:
- Li, Miao;
- Zhang, Xi;
- Wang, Mimi;
- Wang, Yaohui;
- Qian, Jiali;
- Xing, Xiaoxia;
- Wang, Zhiming;
- You, Yang;
- Guo, Kun;
- Chen, Jie;
- Gao, Dongmei;
- Zhao, Yan;
- Zhang, Lan;
- Chen, Rongxin;
- Cui, Jiefeng;
- Ren, Zhenggang
Publication type:
Article
Retrospective analysis of transcatheter arterial chemoembolization treatment for spontaneously ruptured hepatocellular carcinoma.
Published in:
Oncology Letters, 2019, v. 18, n. 6, p. 6423, doi. 10.3892/ol.2019.11037
By:
- Zou, Jixue;
- Li, Chao;
- Chen, Yi;
- Chen, Rongxin;
- Xue, Tongchun;
- Xie, Xiaoying;
- Zhang, Lan;
- Ren, Zhenggang
Publication type:
Article
Arsenic trioxide and sorafenib combination therapy for human hepatocellular carcinoma functions via up‑regulation of TNF‑related apoptosis‑inducing ligand.
Published in:
Oncology Letters, 2018, v. 16, n. 3, p. 3341, doi. 10.3892/ol.2018.8981
By:
- Wang, Lingyan;
- Min, Zhihui;
- Wang, Xiangdong;
- Hu, Mushuang;
- Song, Dongli;
- REN, ZhENggang;
- ChENg, YunfENg;
- Wang, Yanhong
Publication type:
Article
Predicting Disease-Specific Survival for Patients With Primary Cholangiocarcinoma Undergoing Curative Resection by Using a Decision Tree Model.
Published in:
Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.824541
By:
- Quan, Bing;
- Li, Miao;
- Lu, Shenxin;
- Li, Jinghuan;
- Liu, Wenfeng;
- Zhang, Feng;
- Chen, Rongxin;
- Ren, Zhenggang;
- Yin, Xin
Publication type:
Article
Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study.
Published in:
Medical Oncology, 2015, v. 32, n. 3, p. 1, doi. 10.1007/s12032-015-0504-3
By:
- Xue, Tongchun;
- Le, Fan;
- Chen, Rongxin;
- Xie, Xiaoying;
- Zhang, Lan;
- Ge, Ningling;
- Chen, Yi;
- Wang, Yanhong;
- Zhang, Boheng;
- Ye, Shenglong;
- Ren, Zhenggang
Publication type:
Article

Found: 51